MicroRNA-762 Modulates Lipopolysaccharide-induced Acute Lung Injury via SIRT7

Cong Wang1, Yun Chen2, Ni-Tao Cheng3

  • 1Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.

Abstract

Insights

MicroRNA-762 (miR-762) exacerbates lipopolysaccharide (LPS)-induced acute lung injury (ALI) by increasing inflammation and oxidative stress. Inhibiting miR-762 protects against ALI by upregulating SIRT7, suggesting miR-762 as a therapeutic target.

Area of Science:

  • Pulmonary Medicine
  • Molecular Biology
  • Inflammation Research

Background:

  • Acute lung injury (ALI) pathogenesis involves inflammation and oxidative stress.
  • MicroRNA-762 (miR-762) is linked to inflammation and oxidative stress but its role in ALI is unknown.

Purpose of the Study:

  • Investigate the role of miR-762 in lipopolysaccharide (LPS)-induced ALI.
  • Elucidate the underlying mechanisms of miR-762 action in ALI.

Main Methods:

  • Established an LPS-induced ALI mouse model.
  • Administered miR-762 antagomir/agomir and used adenoviral vectors for SIRT7 knockdown.

Main Results:

  • LPS increased miR-762 expression in lungs.
  • miR-762 antagomir reduced inflammation, oxidative stress, and ALI severity.
  • miR-762 agomir worsened ALI.
  • SIRT7 upregulation was crucial for miR-762 antagomir's protective effects; SIRT7 knockdown abolished these benefits.

Conclusions:

  • miR-762 contributes to LPS-induced ALI pathogenesis by modulating inflammation and oxidative stress.
  • This effect is dependent on miR-762's regulation of SIRT7 expression.
  • miR-762 may represent a therapeutic target for ALI treatment.